Health-related quality of life in patients with unresectable hepatocellular carcinoma treated with SIRT and nivolumab: a sub-analysis of the NASIR-HCC trial

Authors

Institutions

Publication Details

Journal
Journal of Patient-Reported Outcomes
Published
2025-04-08
DOI
https://doi.org/10.1186/s41687-025-00873-6
Citations
1
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
1.32

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Health-related quality of life in patients with unresectable hepatocellular carcinoma treated with SIRT and nivolumab: a sub-analysis of the NASIR-HCC trial

José Luis Lledó-Navarro, Ion Agirrezabal, Manuel de la Torre‐Aláez, Marı́a Varela et al.
1 citations
Journal of Patient-Reported Outcomes
Hepatocellular Carcinoma Treatment and Prognosis
1.32
article

Health-related quality of life in patients with unresectable hepatocellular carcinoma treated with SIRT and nivolumab: a sub-analysis of the NASIR-HCC trial

José Luis Lledó-Navarro, Ion Agirrezabal, Manuel de la Torre‐Aláez, Marı́a Varela, Sara Lorente, Ana Matilla, Gemma Iserte, Milagros Testillano, José Ignacio Bilbao, Mercedes Iñarrairaegui, Johannes Pöhlmann, Macarena Rodríguez‐Fraile, Carlos Gómez-Martín, Josepmaria Argemí, Richard Fulton Pollock, Laura Márquez, María Reig, Bruno Sangro, Juan Ignacio Arenas
article en
1 citations

Abstract

No abstract available for this paper.
Journal of Patient-Reported OutcomesVol. 9(1)
Universidad de Alcalá (ES), Hospital General Universitario Gregorio Marañón (ES), Biogipuzkoa Health Research Institute (ES), Hospital Universitario 12 De Octubre (ES), Hospital Clínic de Barcelona (ES), Sirtex (Germany) (DE), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES), Hospital Universitario Central de Asturias (ES), Clinica Universidad de Navarra (ES), Hospital Clínico Universitario Lozano Blesa (ES), Hospital de Cruces (ES), A-T Society (GB), Hospital Universitario Ramón y Cajal (ES), Covalence Research, Universitat de Barcelona (ES)
Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Gilead Sciences, Boston Scientific Corporation, Eisai, Ipsen, Sirtex Medical
Peace, Justice and strong institutions
Openalex Percentile: Top 22%
Hepatocellular Carcinoma Treatment and Prognosis
1.32
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.